Acadia Pharmaceuticals (ACAD) EBT Margin (2010 - 2026)
Acadia Pharmaceuticals' (ACAD) quarterly EBT Margin came in at 1.49% in Q1 2026, down 989.0% year-on-year from 0.17% in Q1 2025, and down 83.97% quarter-over-quarter from 9.26% in Q4 2025.
Acadia Pharmaceuticals (ACAD) EBT Margin (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' EBT Margin history runs 17 years deep, the most recent figure standing at 1.49% for Q1 2026.
- On a quarterly basis, EBT Margin fell 989.0% year-over-year to 1.49% in Q1 2026; TTM through Mar 2026 was 10.51%, a 1608.0% decrease from a year earlier, with the FY2025 full-year figure at 12.96%, down 1398.0% from the prior year.
- EBT Margin slipped to 1.49% in Q1 2026 per ACAD's latest filing, from 9.26% in the prior quarter.
- Across five years, EBT Margin topped out at 62.05% in Q4 2024 and bottomed at 97.49% in Q1 2022.
- The 5-year median for EBT Margin is 9.26% (2025), against an average of 3.39%.
- Across the five-year window, EBT Margin soared 5959 bps in 2023 and slumped 5278 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 29.92% in 2022, then surged by 157 bps to 17.17% in 2023, then surged by 261 bps to 62.05% in 2024, then slumped by 85 bps to 9.26% in 2025, then sank by 84 bps to 1.49% in 2026.
- Per Business Quant, the three latest ACAD EBT Margin figures stand at 1.49% (Q1 2026), 9.26% (Q4 2025), and 16.0% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn | 1.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.49% |
| Dec 31, 2025 | 9.26% |
| Sep 30, 2025 | 16.00% |
| Jun 30, 2025 | 15.19% |
| Mar 31, 2025 | 11.38% |
| Dec 31, 2024 | 62.05% |
| Sep 30, 2024 | 15.50% |
| Jun 30, 2024 | 15.37% |
| Mar 31, 2024 | 10.20% |
| Dec 31, 2023 | 17.17% |
| Sep 30, 2023 | -24.61% |
| Jun 30, 2023 | 3.84% |
| Mar 31, 2023 | -37.90% |
| Dec 31, 2022 | -29.92% |
| Sep 30, 2022 | -20.20% |
| Jun 30, 2022 | -24.95% |
| Mar 31, 2022 | -97.49% |
| Dec 31, 2021 | -32.81% |
| Sep 30, 2021 | -11.24% |
| Jun 30, 2021 | -37.67% |